Literature DB >> 1563918

Effects of cyclosporin A on the course of murine alveolar echinococcosis and on specific cellular and humoral immune responses against Echinococcus multilocularis.

M Liance1, S Bresson-Hadni, D A Vuitton, D Lenys, J P Carbillet, R Houin.   

Abstract

The effects of cyclosporin A (CsA) on Echinococcus multilocularis (E. multilocularis) metacestode growth, and on the specific immune responses of the hosts, were examined in AKR mice. Mice were intra-peritoneally infected with a metacestode homogenate. CsA (40 mg kg(-1) day(-1)) was injected subcutaneously from the 45th day after infection (Group 1), and from the day before infection (Group 2) until the day of autopsy (days 125 and 80, respectively). Results showed that unlike ths situation with some other helminthiases, CsA had no antiparasitic effect, although it lengthened the maturation time of protoscoleces in Group 1. The parasitic burden, unmodified in Group 1, was significantly enhanced in Group 2. This enhancement was associated with a decrease in antibody levels, whereas the delayed-type hypersensitivity was decreased in the two groups. These results confirm the role of cellular immunity in controlling the first stages of the larval development of E. multilocularis and indicate the necessity for a careful follow-up of any recurrence of alveolar echinococcosis in patients treated with CsA after liver transplantation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563918     DOI: 10.1016/0020-7519(92)90075-v

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  10 in total

1.  Renal allograft transplant recipient with ruptured hydatid native kidney.

Authors:  Riyaz Ahmad Bhat; Imtiyaz Wani; Imran Khan; Muzaffar Wani
Journal:  Urol Ann       Date:  2014-07

2.  In vitro efficacy of dicationic compounds and mefloquine enantiomers against Echinococcus multilocularis metacestodes.

Authors:  Britta Stadelmann; Tatiana Küster; Sabrina Scholl; Fabienne Barna; Christian Kropf; Jennifer Keiser; David W Boykin; Chad E Stephens; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

3.  Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.

Authors:  Mar Siles-Lucas; Adriano Casulli; Roberto Cirilli; David Carmena
Journal:  PLoS Negl Trop Dis       Date:  2018-04-20

4.  In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.

Authors:  Tatiana Küster; Britta Stadelmann; Corina Hermann; Sabrina Scholl; Jennifer Keiser; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

5.  In vitro efficacy of triclabendazole and clorsulon against the larval stage of Echinococcus multilocularis.

Authors:  David Richter; Joachim Richter; Beate Grüner; Kathrin Kranz; Juliane Franz; Peter Kern
Journal:  Parasitol Res       Date:  2013-02-28       Impact factor: 2.289

Review 6.  Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay.

Authors:  Dominique Angèle Vuitton; Bruno Gottstein
Journal:  J Biomed Biotechnol       Date:  2010-03-21

Review 7.  Echinococcosis and allergy.

Authors:  Dominique A Vuitton
Journal:  Clin Rev Allergy Immunol       Date:  2004-04       Impact factor: 8.667

8.  Indications and results of liver transplantation for Echinococcus alveolar infection: an overview.

Authors:  Solange Bresson-Hadni; Stéphane Koch; Jean-Philippe Miguet; Michel Gillet; Georges-André Mantion; Bruno Heyd; Dominique-Angèle Vuitton
Journal:  Langenbecks Arch Surg       Date:  2003-08-05       Impact factor: 3.445

9.  In vitro and in vivo effects of 3-bromopyruvate against Echinococcus metacestodes.

Authors:  Qi Xin; Miaomiao Yuan; Huanping Li; Xiaoxia Song; Jun Lu; Tao Jing
Journal:  Vet Res       Date:  2019-11-19       Impact factor: 3.683

10.  Outcome after Discontinuing Long-Term Benzimidazole Treatment in 11 Patients with Non-resectable Alveolar Echinococcosis with Negative FDG-PET/CT and Anti-EmII/3-10 Serology.

Authors:  Rudolf W Ammann; Katrin D M Stumpe; Felix Grimm; Peter Deplazes; Sabine Huber; Kaja Bertogg; Dorothee R Fischer; Beat Müllhaupt
Journal:  PLoS Negl Trop Dis       Date:  2015-09-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.